These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 29575526

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Blocking of fatty acid amide hydrolase activity with PF-04457845 in human brain: a positron emission tomography study with the novel radioligand [(11)C]CURB.
    Boileau I, Rusjan PM, Williams B, Mansouri E, Mizrahi R, De Luca V, Johnson DS, Wilson AA, Houle S, Kish SJ, Tong J.
    J Cereb Blood Flow Metab; 2015 Nov; 35(11):1827-35. PubMed ID: 26082009
    [Abstract] [Full Text] [Related]

  • 4. [11C]CURB: Evaluation of a novel radiotracer for imaging fatty acid amide hydrolase by positron emission tomography.
    Wilson AA, Garcia A, Parkes J, Houle S, Tong J, Vasdev N.
    Nucl Med Biol; 2011 Feb; 38(2):247-53. PubMed ID: 21315280
    [Abstract] [Full Text] [Related]

  • 5. Development of an In Vivo Method to Estimate Effective Drug Doses and Quantify Fatty Acid Amide Hydrolase in Rodent Brain using Positron Emission Tomography Tracer [11C]DFMC.
    Yamasaki T, Ohya T, Mori W, Zhang Y, Wakizaka H, Nengaki N, Fujinaga M, Kikuchi T, Zhang MR.
    J Pharmacol Exp Ther; 2020 Jun; 373(3):353-360. PubMed ID: 32241809
    [Abstract] [Full Text] [Related]

  • 6. Synthesis and preliminary evaluation of a novel positron emission tomography (PET) ligand for imaging fatty acid amide hydrolase (FAAH).
    Chen Z, Hou L, Gan J, Cai Q, Ye W, Chen J, Tan Z, Zheng C, Li G, Xu H, Fowler CJ, Liang SH, Wang L.
    Bioorg Med Chem Lett; 2020 Nov 01; 30(21):127513. PubMed ID: 32860981
    [Abstract] [Full Text] [Related]

  • 7. Fatty Acid Amide Hydrolase Binding in Brain of Cannabis Users: Imaging With the Novel Radiotracer [11C]CURB.
    Boileau I, Mansouri E, Williams B, Le Foll B, Rusjan P, Mizrahi R, Tyndale RF, Huestis MA, Payer DE, Wilson AA, Houle S, Kish SJ, Tong J.
    Biol Psychiatry; 2016 Nov 01; 80(9):691-701. PubMed ID: 27345297
    [Abstract] [Full Text] [Related]

  • 8. The effects of inhibition of fatty acid amide hydrolase (FAAH) by JNJ-42165279 in social anxiety disorder: a double-blind, randomized, placebo-controlled proof-of-concept study.
    Schmidt ME, Liebowitz MR, Stein MB, Grunfeld J, Van Hove I, Simmons WK, Van Der Ark P, Palmer JA, Saad ZS, Pemberton DJ, Van Nueten L, Drevets WC.
    Neuropsychopharmacology; 2021 Apr 01; 46(5):1004-1010. PubMed ID: 33070154
    [Abstract] [Full Text] [Related]

  • 9. The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ASP3652 in First-in-Human and Ascending Multiple Oral Dose Studies in Healthy Subjects.
    Takizawa M, Cerneus D, Michon I, Rijnders S, van der Heide D, Meijer J, Stoelzel M, Sato Y.
    Adv Ther; 2020 Sep 01; 37(9):3878-3900. PubMed ID: 32681461
    [Abstract] [Full Text] [Related]

  • 10. Piperazine and piperidine carboxamides and carbamates as inhibitors of fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL).
    Korhonen J, Kuusisto A, van Bruchem J, Patel JZ, Laitinen T, Navia-Paldanius D, Laitinen JT, Savinainen JR, Parkkari T, Nevalainen TJ.
    Bioorg Med Chem; 2014 Dec 01; 22(23):6694-6705. PubMed ID: 25282655
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Inhibition of fatty acid amide hydrolase by BIA 10-2474 in rat brain.
    Tong J, Mizrahi R, Houle S, Kish SJ, Boileau I, Nobrega J, Rusjan PM, Wilson AA.
    J Cereb Blood Flow Metab; 2017 Nov 01; 37(11):3635-3639. PubMed ID: 27650910
    [Abstract] [Full Text] [Related]

  • 13. Benzylamides and piperazinoarylamides of ibuprofen as fatty acid amide hydrolase inhibitors.
    Deplano A, Cipriano M, Moraca F, Novellino E, Catalanotti B, Fowler CJ, Onnis V.
    J Enzyme Inhib Med Chem; 2019 Dec 01; 34(1):562-576. PubMed ID: 30688118
    [Abstract] [Full Text] [Related]

  • 14. PET imaging of fatty acid amide hydrolase in the brain: synthesis and biological evaluation of an 11C-labelled URB597 analogue.
    Wyffels L, Muccioli GG, Kapanda CN, Labar G, De Bruyne S, De Vos F, Lambert DM.
    Nucl Med Biol; 2010 Jul 01; 37(5):665-75. PubMed ID: 20610171
    [Abstract] [Full Text] [Related]

  • 15. Phenotypic assessment of THC discriminative stimulus properties in fatty acid amide hydrolase knockout and wildtype mice.
    Walentiny DM, Vann RE, Wiley JL.
    Neuropharmacology; 2015 Jun 01; 93():237-42. PubMed ID: 25698527
    [Abstract] [Full Text] [Related]

  • 16. Synthesis and preclinical evaluation of [11C-carbonyl]PF-04457845 for neuroimaging of fatty acid amide hydrolase.
    Hicks JW, Parkes J, Sadovski O, Tong J, Houle S, Vasdev N, Wilson AA.
    Nucl Med Biol; 2013 Aug 01; 40(6):740-6. PubMed ID: 23731552
    [Abstract] [Full Text] [Related]

  • 17. In vitro and in vivo pharmacological characterization of ASP8477: A novel highly selective fatty acid amide hydrolase inhibitor.
    Watabiki T, Tsuji N, Kiso T, Ozawa T, Narazaki F, Kakimoto S.
    Eur J Pharmacol; 2017 Nov 15; 815():42-48. PubMed ID: 29017758
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics, pharmacodynamics and safety studies on URB937, a peripherally restricted fatty acid amide hydrolase inhibitor, in rats.
    Vozella V, Ahmed F, Choobchian P, Merrill CB, Zibardi C, Tarzia G, Mor M, Duranti A, Tontini A, Rivara S, Piomelli D.
    J Pharm Pharmacol; 2019 Dec 15; 71(12):1762-1773. PubMed ID: 31579946
    [Abstract] [Full Text] [Related]

  • 19. Clinical pharmacokinetics, pharmacodynamics, safety, and tolerability of JNJ-54175446, a brain permeable P2X7 antagonist, in a randomised single-ascending dose study in healthy participants.
    Timmers M, Ravenstijn P, Xi L, Triana-Baltzer G, Furey M, Van Hemelryck S, Biewenga J, Ceusters M, Bhattacharya A, van den Boer M, van Nueten L, de Boer P.
    J Psychopharmacol; 2018 Dec 15; 32(12):1341-1350. PubMed ID: 30260294
    [Abstract] [Full Text] [Related]

  • 20. Fatty acid amide hydrolase inhibitors: a patent review (2009-2014).
    Lodola A, Castelli R, Mor M, Rivara S.
    Expert Opin Ther Pat; 2015 Dec 15; 25(11):1247-66. PubMed ID: 26413912
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.